Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

March 2022 | 139 pages | ID: A737DB902647EN
GMD Research

Abstracts

Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co., Ltd.
• ICON Plc
• IQVIA Holdings Inc.
• LSK Asia Pacific Pharma Service Co., Ltd.
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co., Ltd.
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY SERVICE

3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC APPLICATION

4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 ASIA-PACIFIC MARKET 2019-2030 BY COUNTRY

6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.

8 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT

8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. World Economic Outlook, 2021-2031
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market
Table 7. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 8. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 9. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 10. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 11. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 12. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 13. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 14. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 15. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 16. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 17. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 18. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 19. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 20. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 21. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 22. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 23. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 24. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 25. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 26. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn
Table 27. Breakdown of World Market by Key Vendor, 2020, %
Table 28. Charles River Laboratories: Company Snapshot
Table 29. Charles River Laboratories: Product Portfolio
Table 30. CMIC Co. Ltd.: Company Snapshot
Table 31. CMIC Co. Ltd.: Business Segmentation
Table 32. CMIC Co. Ltd.: Revenue by Region, 2018, %
Table 33. Covance Inc.: Company Snapshot
Table 34. Covance Inc.: Product Portfolio
Table 35. Covance Inc.: Revenue by Region, 2020, %
Table 36. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot
Table 37. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation
Table 38. ICON Plc: Company Snapshot
Table 39. ICON Plc: Business Segmentation
Table 40. ICON Plc: Product Portfolio
Table 41. ICON Plc: Revenue by Region, 2020, %
Table 42. IQVIA Holdings Inc.: Company Snapshot
Table 43. IQVIA Holdings Inc.: Business Segmentation
Table 44. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 45. IQVIA Holdings Inc.: Product Portfolio
Table 46. LSK Global Pharma Service Co., Ltd.: Company Snapshot
Table 47. Novotech Pty Ltd: Company Snapshot
Table 48. PAREXEL International Corporation: Company Snapshot
Table 49. PAREXEL International Corporation: Business Segmentation
Table 50. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 51. PAREXEL International Corporation: Product Portfolio
Table 52. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 53. PRA Health Sciences Inc.: Company Snapshot
Table 54. PRA Health Sciences Inc.: Business Segmentation
Table 55. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 56. Quanticate Ltd: Company Snapshot
Table 57. Samsung Bioepis Co., Ltd.: Company Snapshot
Table 58. SGS SA (SGS Life Sciences): Company Snapshot
Table 59. SGS SA (SGS Life Sciences): Business Segmentation
Table 60. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 61. Syneos Health Inc.: Company Snapshot
Table 62. Syneos Health Inc.: Business Segmentation
Table 63. Syneos Health Inc.: Revenue by Region, 2018, %
Table 64. WuXi AppTec Inc.: Company Snapshot
Table 65. Risk Evaluation for Investing in Asia Pacific Market, 2021-2030
Table 66. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030
Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market
Figure 14. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 15. Asia Pacific Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)
Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 18. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 19. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 20. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 21. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 22. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 23. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 24. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 25. Asia Pacific Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 26. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 27. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 28. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 29. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 30. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 31. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 32. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 33. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 34. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 35. Asia Pacific Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)
Figure 36. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 37. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 38. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 39. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 40. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 41. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn
Figure 42. Pharmaceutical CRO Market in China, 2019-2030, $ bn
Figure 43. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn
Figure 44. Pharmaceutical CRO Market in India, 2019-2030, $ bn
Figure 45. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn
Figure 46. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn
Figure 47. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period